ACLS and Amiodarone | ACLS-Algorithms.com

Comments

  1. Mohammed Abbasi says

    Can you please cite evidence showing amio actually helps save lives in this setting? If there is none why is ACLS recommending it? Same goes for epinephrine.
    Dorian et al. and Kudenchuk showed that amio just led to more patients being admitted to the hospital to die or to be vegetables. Kudenchuk et al. in NEJM reported that the rate of survival with good neurologic recovery with amiodarone was similar to that without amiodarone. The benefit if any is so small that it is simply not practical from a cost-benefit comparison.
    There is now good evidence for esmolol in arrhythmogenic storm. ECMO looks promising in select patients.

    Also FYI- procainamide has been shown to be far better than amio at converting VT to sinus rhythm.

  2. Pangeran says

    i would like to ask why amiodarone cannot be diluted with NS?is it will be precipitated.
    ANd i’d like to ask i got some patient VT pulseless then i did some DC shock then the patient become VF,i did some DC shock again,according to ACLS the 2nd DC shock i should give him epinephrine right?but how if the ecg changes like this?should i start DC without epi or should i continue the algorithm DC with epi?

    Then short story,the patient become accelerated idioventricular rhythm with pulse,what should i do?thanks

    • Jeff with admin. says

      1. Amiodarone can precipitate when diluted with normal saline.
      2. Correct. After the 2nd shock during CPR, you will give epinephrine or vasopressin.
      3. You can give the epinephrine after the 2nd shock whether or not the rhythm changes from pulseless VT or VF.
      4. If the patient had ROSC but continue to have an arrhythmia, your best option according to AHA ACLS protocol would be to give an amiodarone bolus and then start an amiodarone infusion.

      Kind regards,
      Jeff

  3. AM says

    Hi – if a patient is in VTACH, and no shock is administered, should they be given amiodarone. A fellow cardiologist said that if amiodarone when a person is in VTACH and without a shock, it can put someone in a cardio depressive state?

    • Jeff with admin. says

      If a patient has stable VT and no shock is administered, amiodarone would be considered a medication of choice for the treatment of this arrhythmia. The statement about a “cardio depressive state” would be anecdotal information according to an individual experience. This is not my experience with amiodarone. I have seen amiodarone used successfully a number of times for stable VT and I have not seen any “cardio depressive state.”

      Kind regards,
      Jeff

    • Jeff with admin. says

      Post stabilization management may include antiarrhythmics like amiodarone. There are not specific guidelines for antiarrhythmic use provided by the American Heart Association for post-conversion of VT. Amiodarone would definitely be indicated if arrhythmias persist in the post conversion period. In my experience it is quite common for physicians to begin an amiodarone infusion after the initial bolus.
      Kind regards,
      Jeff

  4. JANINE D says

    i have been in ccl for years &recently transferred to competition facility. they have “their own protocols” for acls drugs it sems.
    i have always pushed amio 300 iv for pulseless vf/vt. they had issue with that.
    they also have a partial fill d5w of 25 cc in emerg box for diluting
    please spell out exactly how to push and dilute and rates
    thanx

    • Jeff with admin. says

      You would dilute with 20ml of D5W and give it as an IV push. Push the medication as quickly as you can press the plunder down. Make sure to follow with 20ml of NS.
      Kind regards,
      Jeff

  5. Tena Flanary says

    Thank you, Jeff!! Wow, this was so helpful to read. I have to take ACLS for the first time in a month. I would love to learn so much more from you. Thank you for sharing.

    Tena

    • Jeff with admin. says

      At least until the next cycle of CPR begins. At least approx. 3 minutes. The main point would be to ensure that the first dose gets to the central circulation and is able to deliver some affect before giving another dose. Effective CPR is the key.

      Kind regards,
      Jeff

  6. Lori says

    Hi there,

    If an amiodarone boluses are given for persistent pulseless VF, how important is it to begin an IV infusion soon after the bolus? Serum concentrations decrease rapidly (30-45 minutes) after an IV bolus, I think because of the drug’s distribution into the tissues. Does this mean that it is important to begin the 1mg/min infusion soon after the bolus? And if so, how soon?

  7. Ramon says

    I would like to ask regarding my patient in the ED… He came in with an unstable VT and was converted to sinus after a single 100J sync cardioversion. While working up (ECG, Extracting blood, starting line, etc.), the patient had another unstable VT which was again converted to sinus after a single 100J sync cardioversion. After about 5 minutes, patient had another unstable VT and was converted to sinus by 100J sync cardioversion. My question is:

    1. Is it reasonable to start an antiarrhythmic drug to my patient (I started Amiodarone)?
    2. Do you have to give a loading dose (Amiodarone 150mg slow IV in 10 minutes) prior to starting a drip even if current cardiac monitor reading is already sinus?
    3. What does AHA stands regarding prophylactic antiarhythmics?

    • Jeff with admin. says

      1. Yes it is reasonable.
      2. You should give a loading dose if you are dealing with refractory VT.
      3. The stand regarding no prophylactic use of antiarrhythmics is strictly speaking of use after conversion from one episode of pulseless VT or VF. It would not apply in this case. Amiodarone would be indicated since the pt. had refractory VT with a pulse.

      Kind regards,
      Jeff

  8. hamid says

    thanks alot mr jeff for your exellent answers to others questions; i read all of the questions and your verry educational answers and learn very things ;thanks alot again mr jeff

  9. Michael says

    What is AHA recommendation for recurrent VF/VT after amio was given at 300mg, and then at 150 mg? CPR, defib and epi are being done as recommended. I wanted to know if AHA recommends continuing amio at 150 mg IVP, and continuing if need be up to 2.2 gms, or would you switch to a different antiarrhythmic such as lido since VF/VT did not convert after 450 mg total of amio was given.

    • Jeff with admin. says

      Alternative antiarrhythmics may be attempted after amiodarone, but AHA does not hold a strong position on their use as there is no evidence that the use of any antiarrhythmics improve survival to hospital discharge. If amiodarone has not been effective after the first 2 doses then then an alternative like lidocaine could be attempted rather than continuing with amiodarone which has not been effective.

      Kind regards,
      Jeff

  10. Holly says

    I have a case that I can’t decide which treatment to choose: A pt with ventricular fibrillation has received multiple defibrillations, epinephrine at the appropriate dose, and an initial dose of amiodarone 300 mg IV. The physician would like to give a second dose of amiodarone but is not sure how it should be administered. He consults you to assist with preparation of the next dose of amiodarone. What do you suggest?

    Would I choose:
    1. Repeat amiodarone 300 mg IV push
    2. Amiodarone 150mg diluted in 100 ml D5W
    3. Amiodarone 150 mg IV push
    4. Start an amiodarone infusion at 1mg/min

    • Jeff with admin. says

      I would choose #3 which would be appropriate for the cardiac arrest algorithm. This would be done during chest compressions. This would be the proper intervention according to the American Heart Association guidelines.

      Kind regards,
      Jeff

  11. Kevin says

    I remember after successfull conversion of VF a lidocaine bolus was given along with a maintence infusion of 2 – 4 mg/min. After successfull conversion of VF – to ROSC (say sinus) today in ACLS there is no bolus of amnioderone???

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy